troglitazone has been researched along with tretinoin in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (18.92) | 18.2507 |
| 2000's | 18 (48.65) | 29.6817 |
| 2010's | 12 (32.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Asou, H; Holden, S; Koeffler, HP; Koshizuka, K; Kubota, T; Miyoshi, I; Said, JW; Williamson, EA | 1 |
| Bernlohr, DA; Frohnert, BI; Hui, TY | 1 |
| Burris, TP; Cryan, E; Demarest, KT; Osborne, MC; Pelton, PD; Zhou, L | 1 |
| Asou, H; Elstner, E; Kamada, N; Koeffler, HP; Kubota, T; Verbeek, W; Williamson, E | 1 |
| Canas, X; Irie, Y; Kimura, K; Nagase, I; Saito, M; Yoshida, S; Yoshida, T | 1 |
| Huang, H; Jazayeri, A; Kuparadze, K; Nau, H; O'Brien, WF; Porter, GW; Porter, KB; Spellacy, WN; Tsibris, JC; Tzimas, G | 1 |
| Koeffler, HP; Mehta, RG; Patel, MK; Williamson, E | 1 |
| Breyer, MD; Breyer, RM; Davis, L; Guan, YF; Zhang, YH | 1 |
| Ahn, YH; Cha, JY; Kim, HI; Kim, JW; Kim, KS; Kim, SH | 1 |
| Kitamura, S; Kiyohara, T; Matsuzawa, Y; Miyazaki, Y; Nagasawa, Y; Shinomura, Y; Toyota, M | 1 |
| Breyer, B; Cheng, H; Feng, T; Haydon, RC; He, TC; Ishikawa, A; Jiang, W; Montag, A; Peabody, T; Simon, MA; Zhou, L | 1 |
| Dono, K; Hayashi, N; Monden, M; Nagano, H; Nakamori, S; Okami, J; Sakon, M; Takahashi, Y; Tsujie, M; Umeshita, K | 1 |
| Aoun, P; Simpkins, JW; Watson, DG | 1 |
| Dono, K; Hayashi, N; Hiraoka, N; Monden, M; Nagano, H; Nakamori, S; Okami, J; Sakon, M; Tsujie, M; Umeshita, K | 1 |
| Hashimoto, Y; Imamura, M; Itami, A; Ito, T; Kaganoi, J; Kawabe, A; Kawamura, J; Maeda, M; Shimada, Y; Watanabe, G | 1 |
| Chen, JY; Cheng, AL; Hsu, C; Shen, YC | 1 |
| Camacho, IE; De Strooper, B; Dominguez, D; Merchiers, P; Serneels, L; Spittaels, K | 1 |
| Dansette, PM; Jaouen, M; Johnson, EF; Macherey, AC; Mansuy, D; Marques-Soares, C; Melet, A; Sari, MA; Schoch, GA | 1 |
| Arai, H; Chun, TH; Doi, K; Fukunaga, Y; Inoue, M; Itoh, H; Masatsugu, K; Nakao, K; Saito, T; Sakaguchi, S; Sawada, N; Tanaka, T; Yamashita, J | 1 |
| Heaney, AP | 1 |
| Buechler, C; Kirchner, S; Laberer, S; Neumeier, M; Schäffler, A; Schölmerich, J; Weigert, J; Weiss, T | 1 |
| Kong, J; Li, YC | 1 |
| Al-Makdissy, N; Becuwe, P; Chedotal, A; Collet, P; Dauça, M; Devignes, MD; Domenjoud, L; Donner, M; Huin-Schohn, C; Kerjan, G; Murad, H; Schohn, H | 1 |
| Dansette, PM; Johnson, EF; Sansen, S; Schoch, GA; Stout, CD; Yano, JK | 1 |
| Beckmann, MW; Faschingbauer, F; Goecke, TW; Henke, C; Langbein, M; Ruebner, M; Schild, RL; Schmidt, D; Strick, R; Strissel, PL | 1 |
| Bae, KH; Choi, HR; Kim, DM; Kim, IC; Kim, WK; Lee, SC; Park, A; Shin, SM | 1 |
| Cui, T; Liu, L; Liu, Y; Mou, J; Pei, DS; Zhang, SN; Zhu, ZA | 1 |
| Gambill, J; Hanson, AM; Kelley, MD; Phomakay, V; Staten, CT | 1 |
2 review(s) available for troglitazone and tretinoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Novel medical approaches for the treatment of Cushing's disease.
Topics: Antineoplastic Agents; Chromans; Humans; Ligands; Pituitary ACTH Hypersecretion; PPAR gamma; Receptors, Retinoic Acid; Thiazolidinediones; Tretinoin; Troglitazone | 2004 |
35 other study(ies) available for troglitazone and tretinoin
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Differentiation; Chromans; Drug Synergism; Humans; Ligands; Male; Mice; Mice, Nude; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin; Troglitazone; Tumor Cells, Cultured | 1998 |
Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene.
Topics: 3T3 Cells; Animals; Base Sequence; Carrier Proteins; Cell Differentiation; Chromans; Dimerization; DNA; DNA-Binding Proteins; Fatty Acid Transport Proteins; Membrane Proteins; Membrane Transport Proteins; Mice; Molecular Sequence Data; Oleic Acid; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection; Tretinoin; Troglitazone; Up-Regulation | 1999 |
A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Topics: Adipocytes; Animals; Base Sequence; Carrier Proteins; Cells, Cultured; Chromans; Diabetes Mellitus; DNA Probes; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Female; Gene Expression Regulation; Genetic Techniques; Humans; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Molecular Sequence Data; Myelin P2 Protein; Neoplasm Proteins; Nerve Tissue Proteins; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Tretinoin; Troglitazone; Tumor Suppressor Proteins | 1999 |
Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids.
Topics: Alitretinoin; Antineoplastic Agents; Antioxidants; Cell Cycle; Cell Differentiation; Cell Division; Chromans; DNA-Binding Proteins; HL-60 Cells; Humans; Leukemia, Myeloid; Receptors, Cytoplasmic and Nuclear; Superoxides; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin; Troglitazone; Tumor Cells, Cultured; U937 Cells | 1999 |
Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes.
Topics: Alitretinoin; Animals; Carrier Proteins; Cells, Cultured; Chromans; Dimerization; Drug Synergism; Epoprostenol; Gene Expression Regulation; Ion Channels; Mitochondrial Proteins; Muscle, Skeletal; Oleic Acid; Palmitates; Protein Isoforms; Rats; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin; Triiodothyronine; Troglitazone; Uncoupling Protein 3 | 1999 |
Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha, and all-trans retinoic acid than myometrium.
Topics: Alitretinoin; Animals; Carcinogens; Chromans; Drug Implants; Estradiol; Female; Guinea Pigs; Humans; Leiomyomatosis; Menstrual Cycle; Myometrium; Neoplasm Proteins; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin; Troglitazone; Uterine Neoplasms | 1999 |
A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Carcinogens; Chromans; Estradiol; Female; Ligands; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Organ Culture Techniques; Precancerous Conditions; Progesterone; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoid X Receptors; Retinoids; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin; Troglitazone | 2000 |
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Carcinoma, Transitional Cell; Carrier Proteins; Cell Death; Chromans; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; DNA, Complementary; Dose-Response Relationship, Drug; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; G1 Phase; Humans; Immunoblotting; In Situ Hybridization; Ligands; Luciferases; Myelin P2 Protein; Neoplasm Proteins; Nicotinic Acids; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Ribonucleases; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Transfection; Tretinoin; Troglitazone; Tumor Cells, Cultured; Tumor Suppressor Proteins; Urinary Bladder Neoplasms | 1999 |
Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter.
Topics: Alitretinoin; Animals; Base Sequence; Cell Line; Cells, Cultured; Chromans; Consensus Sequence; Dimerization; DNA-Binding Proteins; Gene Expression Regulation; Glucose Transporter Type 2; Hypoglycemic Agents; Islets of Langerhans; Male; Monosaccharide Transport Proteins; Promoter Regions, Genetic; Protein Multimerization; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Recombinant Fusion Proteins; Recombinant Proteins; Retinoid X Receptors; Sequence Alignment; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Transfection; Tretinoin; Troglitazone | 2000 |
Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1.
Topics: Alitretinoin; Animals; Antineoplastic Agents; Blotting, Northern; Blotting, Western; Carcinoma; Cell Division; Chromans; Cyclin D1; Dose-Response Relationship, Drug; Drug Synergism; G1 Phase; Humans; Pancreatic Neoplasms; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection; Tretinoin; Troglitazone; Tumor Cells, Cultured | 2002 |
Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Division; Chromans; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Osteosarcoma; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Neoplasm; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Tretinoin; Troglitazone; Tumor Cells, Cultured | 2002 |
Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Topics: Alitretinoin; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Cell Division; Chromans; Cyclin D1; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; In Situ Nick-End Labeling; Nuclear Proteins; Pancreatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Tretinoin; Troglitazone; Tumor Cells, Cultured | 2003 |
Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells.
Topics: Alitretinoin; Animals; Cell Line; Cell Survival; Chromans; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Humans; Hydrogen Peroxide; Mice; Neuroprotective Agents; Oxidation-Reduction; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Time Factors; Transcription Factors; Tretinoin; Troglitazone | 2003 |
Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Topics: Adenocarcinoma; Alitretinoin; Antineoplastic Agents; Apoptosis; Biliary Tract Neoplasms; Cell Differentiation; Cell Division; Chromans; Drug Screening Assays, Antitumor; Drug Synergism; Gastrointestinal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Pancreatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Tretinoin; Troglitazone; Tumor Cells, Cultured | 2003 |
Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma.
Topics: Alitretinoin; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Squamous Cell; Caspases; Cell Division; Chromans; Drug Evaluation; Esophageal Neoplasms; Humans; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazolidinediones; Transcription Factors; Tretinoin; Troglitazone; Tumor Cells, Cultured | 2003 |
Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Division; Chromans; Dose-Response Relationship, Drug; Drug Synergism; Humans; Liver Neoplasms; Thiazolidinediones; Tretinoin; Troglitazone; Tumor Cells, Cultured | 2004 |
Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide.
Topics: Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Anilides; Animals; Aspartic Acid Endopeptidases; Cell Line; Cell Line, Tumor; Cells, Cultured; Cerebral Cortex; Chromans; Culture Media, Conditioned; Endopeptidases; Humans; Kidney; Mice; Neuroblastoma; Neuroglia; Neurons; Peptide Fragments; Pioglitazone; PPAR gamma; Protein Processing, Post-Translational; Receptor, Notch1; Receptors, Cell Surface; Recombinant Fusion Proteins; Retinoid X Receptors; Rosiglitazone; Thiazolidinediones; Transcription Factors; Tretinoin; Troglitazone | 2004 |
Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants.
Topics: Amiodarone; Animals; Arginine; Aryl Hydrocarbon Hydroxylases; Asparagine; Catalysis; Chromans; Computer Simulation; Cytochrome P-450 CYP2C8; Diclofenac; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Isoleucine; Models, Molecular; Mutagenesis, Site-Directed; Paclitaxel; Phenylalanine; Rabbits; Serine; Substrate Specificity; Sulfonamides; Thiazolidinediones; Tretinoin; Troglitazone | 2004 |
Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.
Topics: Alitretinoin; Angioplasty, Balloon; Animals; Aorta; Arteriosclerosis; Binding, Competitive; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CCL2; Chromans; Dose-Response Relationship, Drug; Endothelium, Vascular; Gene Expression Regulation; Humans; Macrophages; Male; Monocytes; Pioglitazone; PPAR gamma; Prostaglandin D2; Rabbits; Receptors, CCR2; Receptors, Chemokine; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazolidinediones; Time Factors; Tretinoin; Troglitazone; Vascular Endothelial Growth Factor A; Wound Healing | 2005 |
Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors.
Topics: Adiponectin; Alitretinoin; Animals; Caco-2 Cells; Cell Line; CHO Cells; Chromans; Cricetinae; DNA-Binding Proteins; Fenofibrate; HeLa Cells; Hepatocytes; Humans; Hydroxycholesterols; Liver X Receptors; Orphan Nuclear Receptors; Peroxisome Proliferator-Activated Receptors; Pioglitazone; PPAR alpha; Receptors, Adiponectin; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Retinoid X Receptors; Thiazolidinediones; Tretinoin; Troglitazone; Up-Regulation | 2005 |
Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
Topics: 3T3-L1 Cells; Adipogenesis; Adipose Tissue; Animals; Antineoplastic Agents; Calcitriol; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Chromans; Fibroblasts; Gene Expression; Lipoprotein Lipase; Mice; PPAR gamma; Receptors, Calcitriol; Retinoid X Receptors; Signal Transduction; Thiazolidinediones; Transcription Factor AP-2; Transfection; Tretinoin; Troglitazone; Vitamins | 2006 |
Effects of PPAR and RXR ligands in semaphorin 6B gene expression of human MCF-7 breast cancer cells.
Topics: Alitretinoin; Blotting, Western; Breast Neoplasms; Cell Line; Cell Line, Tumor; Chromans; Dimerization; Fenofibrate; Gene Expression; HT29 Cells; Humans; K562 Cells; PPAR alpha; PPAR gamma; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Semaphorins; Thiazoles; Thiazolidinediones; Tretinoin; Troglitazone | 2006 |
Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid.
Topics: Acetates; Alitretinoin; Aryl Hydrocarbon Hydroxylases; Binding Sites; Chromans; Crystallography, X-Ray; Cyclopropanes; Cytochrome P-450 CYP2C8; Felodipine; Heme; Humans; Iron; Leukotriene Antagonists; Ligands; Molecular Conformation; Protein Binding; Quinolines; Substrate Specificity; Sulfides; Thiazolidinediones; Tretinoin; Troglitazone | 2008 |
Regulation of the human endogenous retroviral Syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPARγ/RXRα in placentogenesis.
Topics: Alitretinoin; Cell Fusion; Cell Line; Chromans; Cyclic AMP-Dependent Protein Kinases; Endogenous Retroviruses; Female; Fetal Growth Retardation; Gene Expression Regulation; Gene Products, env; HELLP Syndrome; Humans; Mitogen-Activated Protein Kinase 14; Placenta; Placentation; PPAR gamma; Pre-Eclampsia; Pregnancy; Pregnancy Proteins; Response Elements; Retinoid X Receptor alpha; RNA Interference; RNA, Small Interfering; Signal Transduction; Thiazolidinediones; Tretinoin; Troglitazone; Trophoblasts | 2012 |
Retinoic acid inhibits adipogenesis via activation of Wnt signaling pathway in 3T3-L1 preadipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Base Sequence; beta Catenin; Cell Differentiation; Chromans; DNA Primers; Mice; PPAR gamma; Real-Time Polymerase Chain Reaction; Signal Transduction; Thiazolidinediones; Tretinoin; Troglitazone; Wnt Proteins | 2013 |
Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Chromans; Down-Regulation; Humans; Hypoglycemic Agents; Intercalating Agents; PPAR gamma; Propidium; Proto-Oncogene Proteins c-bcl-2; Retinoid X Receptors; Stomach Neoplasms; Thiazolidinediones; Tretinoin; Troglitazone; Up-Regulation | 2013 |
9-cis-retinoic Acid and troglitazone impacts cellular adhesion, proliferation, and integrin expression in K562 cells.
Topics: Alitretinoin; Biological Availability; Cell Adhesion; Cell Proliferation; Chromans; Extracellular Matrix Proteins; Fibronectins; Humans; Integrin alpha5; K562 Cells; Oligopeptides; Thiazolidinediones; Time Factors; Tretinoin; Troglitazone; Vitronectin | 2014 |